Telomir Pharmaceuticals, Inc.’s TELO share price has surged by 11.76%, which has investors questioning if this is right time ...
Sparks flew at the very first session of the 38th Guam Legislature on Monday over Gov. Lou Leon Guerrero’s appointees to fill ...
Sparks flew at the very first session of the 38th Guam Legislature on Monday over Gov. Lou Leon Guerrero’s appointees to fill ...
TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...
What began as a routine legislative session quickly escalated into a heated debate over the CHamoru Land Trust Commission ...
Pickup trucks have long been associated with size, power, and rugged off-road capability, but what if you could get all that ...
Telomir Pharmaceuticals (TELO) announced preclinical findings demonstrating that Telomir-1 reduces tumor size by approximately 50% in a ...
Telomir Pharmaceuticals (NASDAQ: TELO) announced preclinical findings showing that its telomere-elongating drug, Telomir-1, reduced tumor size by app ...
The compact electric pickup truck market is gaining momentum with the MT1, an electric pickup from U.S. EV startup TELO ...
The American School of Marrakech hosted a special iftar, bringing together families, educators, and diplomats to celebrate ...
Telomir-1 shows potential in oncology and age-related diseases, with new findings on its role in tumor suppression and ...
enabling precise regulation of copper metabolism and interacting with essential ions such as copper, iron, and zinc. Price Action: TELO stock closed at $4.12 on Tuesday.